[Clinical characteristics and outcome of 216 indolent B cell lymphomas]
- PMID: 26876256
- PMCID: PMC7342303
- DOI: 10.3760/cma.j.issn.0253-2727.2016.01.012
[Clinical characteristics and outcome of 216 indolent B cell lymphomas]
Figures
References
-
- Isaacson PG, Piris MA, Berger F, et al. Splenic B-cellmarginal zone ymphoma, in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues[M] 4th ed. Lyon: IARC Press; 2008. pp. 218–219.
-
- Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma[J] J Clin Oncol. 2007;25(5):579–586. - PubMed
-
- Hermine O, Lefrère F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection[J] N Engl J Med. 2002;347(2):89–94. - PubMed
-
- Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index[J] Blood. 2004;104(5):1258–1265. - PubMed
